Problematic areas in the reporting of endometrial carcinomas in hysterectomy specimens

Diagnostic Histopathology

Volumn 15, Issue 12, 2009, Pages 571-581

  McCluggage, W Glenn ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

endometrial carcinoma; prognosis; staging; uterus

Indexed keywords

ARTICLE; CANCER STAGING; ENDOMETRIUM CARCINOMA; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; PERITONEUM; PROGNOSIS; UTERINE TUBE;

EID: 70449534867     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.09.004     Document Type: Article

References (74)

1. Clement P.B., and Young R.H. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 9 (2002) 145-184
2. Clement P.B., and Young R.H. Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 11 (2004) 117-142
3. McCluggage W.G. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 59 (2006) 801-812
4. Alkushi A., Abdul-Rahman Z.H., Lim P., et al. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol 29 (2005) 295-304
5. Houghton J.P., Roddy S., Carroll S., and McCluggage W.G. A simple method for the prevention of endometrial autolysis in hysterectomy specimens. J Clin Pathol 57 (2004) 332-333
6. FIGO Announcements, stages- 1988 Revision. Gynecol Oncol 35 (1989) 125
7. Jacques S.M., Qureshi F., Munkarah A., and Lawrence W.D. Interinstitutional surgical pathology review in gynecologic oncology: II. Endometrial cancer in hysterectomy specimens. Int J Gynecol Pathol 17 (1998) 42-45
8. Creasman W.T., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. Int J Gynaecol Obstet 83 (2003) 79-118
9. Ali A., Black D., and Soslow R.A. Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 26 (2007) 115-123
10. Williams J.W., and Hirschowitz L. Assessment of uterine wall thickness and position of the vascular plexus in the deep myometrium: implications for the measurement of depth of myometrial invasion of endometrial carcinomas. Int J Gynecol Pathol 25 (2006) 59-64
11. Jacques S.M., and Lawrence W.D. Endometrial adenocarcinoma with variable-level myometrial involvement limited to adenomyosis. Gynecol Oncol 37 (1990) 401-407
12. Hall J.B., Young R.H., and Nelson Jr. J.H. The prognostic significance of adenomyosis in endometrial carcinoma. Gynecol Oncol 17 (1984) 32-40
13. Hernandez E., and Woodruff J.D. Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 138 (1980) 827-832
14. McCluggage W.G., Sumathi V.P., and Maxwell P. CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 39 (2001) 273-278
15. Sroden M., Klein W.M., and Kurman R.J. CD10 immunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Am J Surg Pathol 27 (2003) 786-789
16. Nascimento A.F., Hirsh M.S., Cviko A., et al. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Mod Pathol 16 (2003) 22-27
17. Sasaki T., Sugiyama T., Nanjo H., et al. Endometrial adenocarcinoma arising from adenomyosis: report and immunohistochemical analysis of an unusual case. Pathol Int 51 (2001) 308-313
18. Koshiyama M., Suzuki A., Ozawa M., et al. Adenocarcinomas arising from adenomyosis uteri: a report of four cases. Int J Gynecol Pathol 21 (2002) 239-245
19. Longacre T.A., and Hendrickson M.R. Diffusely infiltrative endometrial adenocarcinoma. An adenoma malignum pattern of myoinvasion. Am J Surg Pathol 23 (1999) 69-78
20. Landry D., Mai K.T., Senterman M.K., et al. Endometrioid adenocarcinoma of the uterus with a minimal deviation invasive pattern. Histopathology 42 (2003) 77-82
21. Mai K.T., Perkins D.G., Yazdi H.M., and Thomas J. Endometrioid carcinoma of the endometrium with an invasive component of minimal deviation carcinoma. Hum Pathol 33 (2002) 856-858
22. Mittal K.R., and Barwick K.W. Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis. Am J Surg Pathol 12 (1988) 754-758
23. Kalyanasundaram K., Ganesan R., Perunovic B., and McCluggage G. Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis. Int J Surg Pathol (2008 Dec 30) [Epub ahead of print]
24. Murray S.K., Young R.H., and Scully R.E. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol 22 (2003) 324-333
25. Lee K.R., Vacek P.A., and Belinsen J.L. Traditional and non-traditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol Oncol 54 (1994) 10-18
26. Jordan L.B., and Al-Nafussi A. Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma. Int J Gynecol Cancer 12 (2002) 42-48
27. Eltabbakh G.H., and Moore A.D. Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 74 (1999) 80-85
28. Fanning J., Alvarez P.M., Tukada Y., et al. Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol Oncol 40 (1991) 46-47
29. Ayhan A., Taskiran C., Celik C., et al. The long-term survival of women with surgical stage II endometrioid type endometrial cancer. Gynecol Oncol 93 (2004) 9-13
30. Jobsen J.J., Schutter E.M., Meerwaldt J.H., et al. Treatment results in women with clinical stage I and pathologic stage II endometrial carcinoma. Int J Gynecol Cancer 11 (2001) 49-53
31. Scott M., Lyness R.W., and McCluggage W.G. Atypical reactive proliferation of endocervix: a common lesion associated with endometrial carcinoma and likely related to prior endometrial sampling. Mod Pathol 19 (2006) 470-474
32. Tambouret R., Clement P.B., and Young R.H. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. Am J Surg Pathol 27 (2003) 1080-1088
33. Nayar N.G., Cross P.A., Bulmer J.N., et al. Comparison of examination of the entire uterine cervix with routine cervical sampling in hysterectomy specimens from women with endometrial cancer. J Clin Pathol 61 (2008) 621-622
34. Stefansson I.M., Salvesen H.B., Immervoll H., and Akslen L.A. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology 44 (2004) 472-479
35. Gal D., Recio F.O., Zamurovic D., and Tancer M.L. Lymphovascular space involvement- a prognostic indicator in endometrial adenocarcinoma. Gynecol Oncol 42 (1991) 142-145
36. Hanson M.B., van Nagell Jr. J.R., Powell D.E., et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer 55 (1985) 1753-1757
37. Inoue Y., Obata K., Abe K., et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer 78 (1996) 1447-1451
38. Yamazawa K., Seki K., Matsui H., et al. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 91 (2001) 1777-1784
39. McKenney J.K., Kong C.S., and Longacre T.A. Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes. Int J Gynecol Pathol 24 (2004) 73-78
40. Mannelqvist M., Stefansson I., Salvesen H.B., and Akslen L.A. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. Histopathology 54 (2009) 174-183
41. Logani S., Herdman A.V., Little J.V., Moller K.A., et al. Vascular "pseudo-invasion" in laparoscopic hysterectomy specimens: a diagnostic pitfall. Am J Surg Pathol 32 (2008) 560-565
42. Kitahara S., Walsh C., Frumovitz M., et al. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma. A grossing artefact?. Am J Surg Pathol 33 (2009) 298-303
43. O'Hanlan K.A., Huang G.S., Garnier A.C., et al. Total laparoscopic hysterectomy versus total abdominal hysterectomy: cohort review of patients with uterine neoplasia. JSLS 9 (2005) 277-286
44. Culton L.K., Deavers M.T., Silva E.G., et al. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am J Surg Pathol 30 (2006) 844-849
45. Zaino R., Whitney C., Brady M.F., et al. Simultaneously detected endometrial and ovarian carcinomas- a prospective clinicopathologic study of 74 cases: a gynaecologic oncology group study. Gynecol Oncol 83 (2001) 355-362
46. Ulbright T.M., and Roth L.M. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol 16 (1985) 28-34
47. Prat J., Matias-Guiu X., and Barreto J. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical and DNA flow cytometric study of 18 cases. Cancer 65 (1991) 2455-2459
48. Pearl M.L., Johnston C.M., Frank T.S., and Roberts J.A. Synchronous dual primary ovarian and endometrioid carcinoma. Int J Gynaecol Obstet 43 (1993) 305-312
49. Zaino R.J., Unger E.R., and Whitney C. Synchronous carcinomas of the uterine corpus and ovary. Gynecol Oncol 19 (1984) 329-335
50. Ayhan A., Yalcin O.T., Tuncer Z.S., Gurgan T., and Kucukali T. Synchronous primary malignancies of the female genital tract. Eur J Obstet Gynecol Reprod Biol 45 (1992) 63-66
51. Ambros R.A., Sherman M.E., Zahn C.M., Bitterman P., and Kurman R.J. Endometrial intraepithelial carcinoma: distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 26 (1995) 1260-1267
52. Wheeler D.T., Bell K.A., Kurman R.J., and Sherman M.E. Minimal uterine serous carcinoma: Diagnosis and clinicopathologic correlation. Am J Surg Pathol 24 (2000) 797-806
53. McCluggage W.G., Sumathi V.P., and McManus D.T. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of five cases including two associated with tamoxifen therapy. Hum Pathol 34 (2003) 939-943
54. Silva E.G., and Jenkins R. Serous carcinoma in endometrial polyps. Mod Pathol 3 (1990) 120-128
55. Goldstein N.S., and Uzieblo A. WT-1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 117 (2002) 541-545
56. Al-Hussaini M., Stockman A., Foster H., and McCluggage W.G. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histopathology 44 (2004) 109-115
57. McCluggage W.G. WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract. Int J Gynecol Pathol 23 (2004) 97-99
58. Egan J.A., Ionescu M.C., Eapen E., et al. Can analysis of p53 and WT1 assist in distinguishing uterine serous carcinoma from uterine endometrioid carcinoma?. Int J Gynecol Pathol 23 (2004) 119-122
59. Acs G., Pasha T., and Zhang P.J. WT1 is expressed in serous, but not in endometrioid, clear cell or mucinous carcinoma of the peritoneum, fallopian tube, ovaries and endometrium. Int J Gynecol Pathol 23 (2004) 110-118
60. Hashi A., Yuminamochi T., Murata S., et al. Wilms' tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium and peritoneum. Int J Gynecol Pathol 22 (2003) 374-377
61. Matias-Guiu X., Lagarda H., Catasus L., et al. Clonality analysis in synchronous or metachronous tumors of the female genital tract. Int J Gynecol Pathol 21 (2002) 205-211
62. Shenson D.L., Gallion H.H., Powell D.E., and Pieretti M. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 4 (1995) 650-657
63. Moreno-Bueno G., Gamallo C., Perez-Gallego C., et al. Beta-catenin expression pattern, beta-catenin gene mutations and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 10 (2001) 116-122
64. Fujita M., Enomoto T., Wada H., Inoue M., Okudaira Y., and Shroyer K.R. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol 105 (1996) 350-359
65. Brinkmann D., Ryan A., Ayhan A., et al. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. J Natl Cancer Int 96 (2004) 1441-1446
66. Ramus S.J., Elmasry K., Luo Z., et al. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer. Clin Cancer Res 14 (2008) 5840-5848
67. Fadare O., Mariappan M.R., Hileeto D., et al. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol 18 (2005) 673-680
68. Harouny V.R., Sutton G.P., Clark S.A., et al. The importance of peritoneal cytology in endometrial carcinoma. Obstet Gynecol 72 (1988) 394-398
69. McLellan R., Dillon M.B., Currie J.L., et al. Peritoneal cytology in endometrial cancer: a review. Obstet Gynecol Survey 44 (1989) 711-719
70. Zaino RJ. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol 2009; 28: 1-9.
71. Lim S., Kim H.S., Lee K.B., et al. Does the use of a uterine manipulator with an intrauterine balloon in total laparoscopic hysterectomy facilitate tumor cell spillage into the peritoneal cavity in patients with endometrial cancer?. Int J Gynecol Cancer 18 (2008) 1145-1149
72. Sonoda Y., Zerbe M., Smith A., et al. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol 80 (2001) 378-382
73. Eltabbakh G.H., and Mount S.L. Laparoscopic surgery does not increase the positive peritoneal cytology among women with endometrial carcinoma. Gynecol Oncol 100 (2006) 361-364
74. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet 105 (2009) 103-104